ADLAI NORTYE LTD.

Press Releases Adlai Nortye Ltd.

Equities

ANL

US00704R1095

Delayed Nasdaq Other stock markets 20:30:49 28/05/2024 BST			5-day change	1st Jan Change
10.09 ^USD	-3.88%		-20.84%	+12.27%

05-24	Adlai Nortye Ltd. Announces to Present Encouraging Data of the Combination of AN0025 and Definitive Chemoradiotherapy At ASCO 2024	CI
04-08	ADRs Advance, Eco Wave Power Global AB Climbs 213.4%	DJ

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Adlai Nortye Ltd. to Present Encouraging Data of the Combination of AN0025 and Definitive Chemoradiotherapy (dCRT) at ASCO 2024	05-24	GL
Adlai Nortye Ltd. to Present Encouraging Data of the Combination of AN0025 and Definitive Chemoradiotherapy (dCRT) at ASCO 2024	05-24	AQ
Adlai Nortye Announces First Patient Dosed in Randomized Phase II Clinical Trial of Palupiprant (AN0025) for the Treatment of Locally Advanced Rectal Cancer with Radiation Therapy	05-22	GL
Adlai Nortye Announces First Patient Dosed in Randomized Phase II Clinical Trial of Palupiprant (AN0025) for the Treatment of Locally Advanced Rectal Cancer with Radiation Therapy	05-22	AQ
Adlai Nortye Announces Appointment of Dr. Archie Tse as the Head of Research & Development	04-01	AQ
Adlai Nortye Announces Appointment of Dr. Archie Tse as the Head of Research & Development	03-29	GL
Adlai Nortye : Term of use	12-06	PU
Adlai Nortye Announces Completion of Patient Enrollment in Global Phase III Clinical Trial of Buparlisib (AN2025) in Combination with Paclitaxel for the Treatment of Recurrent or Metastatic HNSCC	11-17	GL
Adlai Nortye Announces Completion of Patient Enrollment in Global Phase III Clinical Trial of Buparlisib (AN2025) in Combination with Paclitaxel for the Treatment of Recurrent or Metastatic HNSCC	11-17	AQ
Adlai Nortye Ltd. & Nucleai awarded ESMO 2023 BEST Poster Award	23/10/23	GL
Adlai Nortye : in collaboration with Nucleai, to Present "Utilizing H&E Images and Digital Pathology to Predict Response to Buparlisib in SCCHN" at ESMO 2023	15/10/23	PU
Adlai Nortye Ltd. Announces Closing of Initial Public Offering	03/10/23	GL
Adlai Nortye Ltd. Announces Pricing of Initial Public Offering	29/09/23	GL
Adlai Nortye Ltd. Announces Pricing of Initial Public Offering	29/09/23	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

As early as today, start finding the best investment opportunities!

Optimize my profits

fermer